Farudodstat

N/A

Report date: 2026/02/13 20:01:31
NME

Base Information

Drug NameFarudodstat
Drug Alias NameASLAN-003LAS-186323
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsAlopecia AreataLeukemia, Myeloid, AcuteRheumatic Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAlopecia AreataLeukemia, Myeloid, AcuteRheumatic Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A